Karen Kelly
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.1%
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Surgery top 2%
- Co-authors
- Paul A. BunnDavid R. GandaraKathy S. AlbainRoy S. HerbstPrimo N. LaraJoan H. SchillerJohn J. CrowleySteven D. Averbuch
- Topics
- Lung Cancer Treatments and Mutations (209 papers)Lung Cancer Research Studies (105 papers)Lung Cancer Diagnosis and Treatment (91 papers)
- Journals
- The LancetJAMANucleic Acids Research
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Karen Kelly
379 papers receiving 14.4k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Oncology 9.4k
- Pulmonary and Respiratory Medicine 8.3k
- Molecular Biology 3.4k
- Cancer Research 1.7k
- Surgery 1.3k
Countries citing papers authored by Karen Kelly
This map shows the geographic impact of Karen Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Kelly more than expected).
Fields of papers citing papers by Karen Kelly
This network shows the impact of papers produced by Karen Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Kelly. The network helps show where Karen Kelly may publish in the future.
Co-authorship network of co-authors of Karen Kelly
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Kelly. A scholar is included among the top collaborators of Karen Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Kelly. Karen Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 0 | |
| 8 | 31 | |
| 9 | 60 | |
| 10 | 17 | |
| 11 | 104 | |
| 12 | 59 | |
| 13 | 66 | |
| 14 | DIVERGENT ACTIVITY OF AFATINIB (AFAT) AND CETUXIMAB (CET) IN PATIENT-DERIVED XENOGRAFT (PDX) MODELS OF ACQUIRED ERLOTINIB RESISTANCE. | 2 |
| 15 | 72 | |
| 16 | 421 | |
| 17 | 5 | |
| 18 | 215 | |
| 19 | A phase III open randomized study of Zoladex 3.6 mg depot vs. DES 3 mg per day in untreated advanced prostate cancer: a West Midlands Urological Research Group Study. | 7 |
| 20 | 24 |
About Karen Kelly
Karen Kelly is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 390 papers that have together received 14.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (209 papers), Lung Cancer Research Studies (105 papers) and Lung Cancer Diagnosis and Treatment (91 papers). The work is most often cited by research in Oncology (9.4k citations), Pulmonary and Respiratory Medicine (8.3k citations) and Cancer Research (1.7k citations). Karen Kelly has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Paul A. Bunn, David R. Gandara, Kathy S. Albain, Roy S. Herbst, Primo N. Lara, Joan H. Schiller, John J. Crowley, Steven D. Averbuch, John Crowley and Geoffrey R. Weiss. Their work appears in journals such as The Lancet, JAMA and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.